The combination demonstrated non-inferiority to comparator antiretroviral therapies, meeting the primary efficacy success ...

MSD’s HIV treatment is now back on track after an earlier hit which saw the FDA place a clinical hold on the therapy.

Bengaluru: Prayoga Institute of Education Research on Friday announced its partnership with Merck, a science and technology ...

American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

In a remarkable move to enhance access to science education, Prayoga Institute of Education Research and Merck, a leading ...

president of Merck Research Laboratories, said: ““We are deeply grateful to the researchers and patients who participated in the anacetrapib clinical development programme, and in particular ...

president of Merck Research Laboratories. "We continue to augment our oncology pipeline and look forward to working with the Kelun-Biotech team to advance these candidates to the patients that ...

"To ensure the safe use of these resources, the labs are equipped with safety and ... We are happy to have Merck's support in further enhancing access to quality science education, enabling ...

Dividend-paying stocks are a traditional defensive play, while healthcare faces fewer trade and economic headwinds than most ...

OUSA is an ETF that provides exposure to high-quality U.S. companies that pay regular dividends. The fund tracks the O’Shares ...

New data from the MK-8591A-051 and MK-8591A-052 trials, both investigating the efficacy and safety of 100-mg doravirine and 0.25-mg islatravir as a once-daily 2-drug regimen for virologically ...

Explore why Recursion Pharmaceuticals' AI-driven drug discovery faces challenges in revenue growth, governance, and investor ...